Unlocking the potential of cannabis
The world's leading provider of data, intelligence and strategy for the cannabis industry.
International Cannabis Weekly: Issue 159 out now
July records largest single-month patient growth in Australia as authorisations surge
Social Listening: Positive sentiment dominant ahead of New Zealand referendum
The Cannabis World Map
Click each continent to view key statistics on healthcare, market size and more
Europe
Latin America
North America
Oceania
Africa
Asia
About Us
Learn More
Prohibition Partners unlocks the potential of cannabis through data, intelligence and strategy.
We enable our clients to make better business decisions that deliver transformational growth and disrupt mainstream verticals.
We work with the industry’s most influential stakeholders, some of the world’s best known brands and an unrivalled network of analysts, innovators and advisors.
Reports
See all Reports
Our Services
Find out moreNews + Insights
View All06.08.2020
Earlier today, the TGA of Australia released data on medical cannabis authorisations for July, showing the largest single month increase in prescription approvals to date.
July records largest single-month patient growth in Australia as authorisations surge
04.08.2020
Recent online sentiment analysis has suggested cannabis legislation is now being viewed favourably by citizens in New Zealand.
Social Listening: Positive sentiment dominant ahead of New Zealand referendum
International Cannabis
Weekly
View All
07.08.2020
Issue
159
Australia records record monthly medical cannabis patient growth in July. Online sentiment predominantly positive ahead...
31.07.2020
Issue
158
Germany imports 4,126 kg of medical cannabis during the first half of 2020, US cannabis employment...
24.07.2020
Issue
157
NHS plans to manufacture medicinal cannabis oil for children with severe epilepsy. FDA launches widespread...
17.07.2020
Issue
156
Overcapacity continues to loom over Canadian market despite players slashing costs. Medical cannabis prescriptions grow...
Press
View PageKelis to feature as a panelist and cook live at Prohibition Partners Live
Prohibition Partners Releases Disrupting Drinks
For press inquiries, please contact us at media@prohibitionpartners.com.
What we're saying
As more and more patients, doctors and regulators recognise the medical benefits of legal medical cannabis access, Prohibition Partners expect to see the exponential growth of the industry in Australia to continue. Learn more from our analysis of the data.
https://prohibitionpartners.com/2020/08/06/july-records-largest-single-month-patient-growth-in-australia-as-authorisations-surge/
The Impact Series: Disrupting Drinks details the result of Prohibition Partners’ unique consumer research polling, covering over 15,000 adults across seven-country markets evaluating usage, purchase and attitudes towards cannabinoid-based products: https://prohibitionpartners.com/reports/#disrupting-drinks-report
Switzerland has refunded €42.5 million in taxes to low-THC cannabis farmers and producers, following a court ruling which deemed that their products were unconstitutionally taxed as a tobacco substitute.
https://hempindustrydaily.com/switzerland-refunds-36m-in-taxes-levied-on-low-thc-cannabis-growers-sellers/